Boston Scientific Corp
BSX· NYSE
BSXBoston Scientific Corp
Source filing unavailable
| Metric | Q4 2010 | Q4 2009 | Q4 2008dderived from reported figures |
|---|---|---|---|
| Revenue | $2.00B | $2.08B | — |
| Net Income | $236.00M | -$1.08B | — |
| EPS Diluted | $0.15 | -$0.71 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
